News

We invest in growth stage diagnostic companies and empower them with the full strength of our collective resources, capital, and expertise.

Sapphiros Secures Additional NIH RADx® Support to Advance Next-Gen Molecular Respiratory At-Home Diagnostic

Sapphiros Appoints Healthcare Executive Jackson McAdam as Chief Financial Officer

Sapphiros Launches NowFuture™: A New Era in Personalized Wellness

January 4, 2024

Sapphiros Is Pleased To Announce OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests In Sapphiros

November 22, 2023

Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement

September 26, 2023

Satio Receives Funding From ARPA-H to Develop SatioRx™ a Novel At-home, Remotely Controllable Transdermal Drug Delivery Device